On Wednesday 30th October 2024, Biogen (NASDAQ: BIIB) will be releasing its third quarter financial results. This much awaited announcement will be made before market open.
Wall Street financial experts are forecasting that the company will announce an expected $3.79 profit per share for the quarter. Moreover, the firm is anticipated to disclose a total revenue of $2.43 billion for this specific period.
The company's full-year performance projections, as provided by Wall Street analysts, suggest a total revenue of $9.64 billion. Further, they expect the earnings per share to achieve profit of $16.19 for the fiscal year.
In the same quarter of the previous year, the company's financial statement revealed a per-share income of $4.36. Additionally, the company's overall revenue for that particular period was an impressive $2.53 billion.
The business has scheduled a conference call on 30th October 2024 at 08:30 AM eastern time to discuss Q3 financial results.
Throughout Monday's trading, Biogen (BIIB) shares fluctuated between $181.73 and $185.60, with a trading volume of 1.89 million shares. The stock ended the regular trading session at $185.01, demonstrating an increase of 1.83 percent.
